These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7481841

  • 1. Consequences of 2',2'-difluorodeoxycytidine (gemcitabine) on replicative DNA synthesis in intact HL-60 cells.
    Ross DD, Cuddy DP.
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):26-34. PubMed ID: 7481841
    [Abstract] [Full Text] [Related]

  • 2. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells.
    Ross DD, Cuddy DP.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1619-30. PubMed ID: 7980627
    [Abstract] [Full Text] [Related]

  • 3. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
    Gandhi V, Mineishi S, Huang P, Yang Y, Chubb S, Chapman AJ, Nowak BJ, Hertel LW, Plunkett W.
    Semin Oncol; 1995 Aug 18; 22(4 Suppl 11):61-7. PubMed ID: 7481847
    [Abstract] [Full Text] [Related]

  • 4. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
    Bergman AM, Munch-Petersen B, Jensen PB, Sehested M, Veerman G, Voorn DA, Smid K, Pinedo HM, Peters GJ.
    Biochem Pharmacol; 2001 Jun 01; 61(11):1401-8. PubMed ID: 11331076
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside.
    Bouffard DY, Momparler RL.
    Leuk Res; 1995 Nov 01; 19(11):849-56. PubMed ID: 8551802
    [Abstract] [Full Text] [Related]

  • 6. Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
    Bouffard DY, Momparler LF, Momparler RL.
    Anticancer Drugs; 1991 Feb 01; 2(1):49-55. PubMed ID: 1958852
    [Abstract] [Full Text] [Related]

  • 7. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.
    Ross DD, Cuddy DP, Cohen N, Hensley DR.
    Cancer Chemother Pharmacol; 1992 Feb 01; 31(1):61-70. PubMed ID: 1458561
    [Abstract] [Full Text] [Related]

  • 8. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
    Jiang HY, Hickey RJ, Abdel-Aziz W, Malkas LH.
    Cancer Chemother Pharmacol; 2000 Feb 01; 45(4):320-8. PubMed ID: 10755321
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD, Chen SR, Cuddy DP.
    Cancer Res; 1990 May 01; 50(9):2658-66. PubMed ID: 2328491
    [Abstract] [Full Text] [Related]

  • 12. Effects of fludarabine and gemcitabine on human acute myeloid leukemia cell line HL 60: direct comparison of cytotoxicity and cellular Ara-C uptake enhancement.
    Santini V, D'Ippolito G, Bernabei PA, Zoccolante A, Ermini A, Rossi-Ferrini P.
    Leuk Res; 1996 Jan 01; 20(1):37-45. PubMed ID: 8632676
    [Abstract] [Full Text] [Related]

  • 13. The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.
    Sigmond J, Kamphuis JA, Laan AC, Hoebe EK, Bergman AM, Peters GJ.
    Biochem Pharmacol; 2007 May 15; 73(10):1548-57. PubMed ID: 17324380
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.
    Heinemann V, Xu YZ, Chubb S, Sen A, Hertel LW, Grindey GB, Plunkett W.
    Mol Pharmacol; 1990 Oct 15; 38(4):567-72. PubMed ID: 2233693
    [Abstract] [Full Text] [Related]

  • 15. [Non-clinical studies of gemcitabine--the mode of action and antitumor activities].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1999 Feb 15; 26(3):393-400. PubMed ID: 10065109
    [Abstract] [Full Text] [Related]

  • 16. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
    Lech-Maranda E, Korycka A, Robak T.
    Haematologica; 2000 Jun 15; 85(6):588-94. PubMed ID: 10870114
    [Abstract] [Full Text] [Related]

  • 17. Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay.
    Smid K, Van Moorsel CJ, Noordhuis P, Voorn DA, Peters GJ.
    Int J Oncol; 2001 Jul 15; 19(1):157-62. PubMed ID: 11408937
    [Abstract] [Full Text] [Related]

  • 18. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N, Cournoyer D, Momparler RL.
    Cancer Chemother Pharmacol; 1998 Jul 15; 42(5):373-8. PubMed ID: 9771951
    [Abstract] [Full Text] [Related]

  • 19. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
    Noordhuis P, Kazemier KM, Kasperrs GJ, Peters GJ.
    Leuk Res; 1996 Feb 15; 20(2):127-34. PubMed ID: 8628011
    [Abstract] [Full Text] [Related]

  • 20. Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells.
    Iwasaki H, Huang P, Keating MJ, Plunkett W.
    Blood; 1997 Jul 01; 90(1):270-8. PubMed ID: 9207462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.